Cargando…
A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate Cancer
Immunotherapy represents an attractive avenue for cancer therapy due to its tumour specificity and relatively low frequency of adverse effects compared to other treatment modalities. Despite many advances being made in the field of cancer immunotherapy, very few immunotherapeutic treatments have bee...
Autores principales: | Puig-Saenz, Carles, Pearson, Joshua R. D., Thomas, Jubini E., McArdle, Stéphanie E. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452459/ https://www.ncbi.nlm.nih.gov/pubmed/37626597 http://dx.doi.org/10.3390/biomedicines11082100 |
Ejemplares similares
-
Clinical trials of immunotherapy in triple-negative breast cancer
por: Howard, Frederick M., et al.
Publicado: (2022) -
Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
por: Pearson, Joshua R. D., et al.
Publicado: (2020) -
Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021) -
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches
por: Geurts, Veerle, et al.
Publicado: (2023) -
Future of Triple Negative Breast Cancer: Can Immunotherapy Treat This Deadly Subtype of Breast Cancer?
por: Salimi, Mona
Publicado: (2018)